OyaGen (United States)

Recent papers from OyaGen (United States)

1. Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug propertiesJCI Insight · 2021
2. Cyclic peptides with a distinct arginine-fork motif recognize the HIV trans-activation response RNA in vitro and in cellsJournal of Biological Chemistry · 2021
3. A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical CountermeasuresViruses · 2020
4. Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid LigandsTrends in Biochemical Sciences · 2018
5. HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human CellsACS Chemical Biology · 2017
6. DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315Journal of Biological Chemistry · 2017
7. N-Methylation as a Strategy for Enhancing the Affinity and Selectivity of RNA-binding Peptides: Application to the HIV-1 Frameshift-Stimulating RNAACS Chemical Biology · 2015
8. RNA binding to APOBEC3G induces the disassembly of functional deaminase complexes by displacing single-stranded DNA substratesNucleic Acids Research · 2015
9. The multifaceted roles of RNA binding in APOBEC cytidine deaminase functionsWiley Interdisciplinary Reviews - RNA · 2014
10. High-Affinity Recognition of HIV-1 Frameshift-Stimulating RNA Alters Frameshifting in Vitro and Interferes with HIV-1 InfectivityJournal of Medicinal Chemistry · 2014
11. The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3GRetrovirology · 2007